Study objectives: Cigarette smoking is the prime cause of COPD; however, on
ly a few smokers develop the disease, In a previous study, we demonstrated
that microsatellite DNA instability (MSI) is a detectable phenomenon in spu
tum cells of COPD patients. Therefore, we hypothesize that this genetic alt
eration may indicate susceptibility to COPD.
Design: In order to investigate this hypothesis, ne compared smokers who de
veloped COPD with smokers who did not develop COPD (referred to as non-COPD
smokers).
Setting: Seven highly polymorphic microsatellite markers were targeted on t
he DNA of sputum cells and of WBCs.
Patients and participants: We studied 60 non-COPD smokers and 59 severe COP
D patients with a similar smoking history (mean +/- SD) of 48 +/- 25 and 54
+/- 33 pack-years, respectively (p = 0.77). Non-COPD smokers were tested o
nce; COPD smokers were tested twice, with an interval of 24 months between
tests.
Results: MSI was detected in 14 COPD patients (24%) but in none of the non-
COPD smokers. In 10 COPD patients, MSI was exhibited by one microsatellite
marker; in the remaining 4 COPD patients, MSI was exhibited by two differen
t alleles. The most commonly affected marker was THRA1 on chromosome 17 (43
%). No significant differences were found between MSI-positive and MSI-nega
tive COPD patients for clinical or laboratory; parameters, survival, and de
velopment of lung cancer. No change in the microsatellite alleles was found
between the tests performed with a 24-month interval.
Conclusions: This study demonstrated that MSI was found exclusively in the
sputum cells of smokers with COPD, The results support the hypothesis that
MSI could be part of the complex genetic basis of COPD, and it could be a m
arker of die genetic alteration caused by smoking that allows COPD to devel
op.